                         SEQUENCE LISTING

<110>  The Board of Trustees of the Leland Stanford Junior 
       University
       The United States Government as represented by the 
       Department of Veterans Affairs
       Goldberg, Jeffrey L.
       Chang, Kun-Che
 
<120>  GENETIC THERAPY FOR GLAUCOMA AND OPTIC NEUROPATHIES

<130>  STAN-1814WO

<140>  PCT/US 2022/014949
<141>  2022-02-02

<150>  US 63/145,161
<151>  2021-02-03

<160>  2     

<170>  PatentIn version 3.5

<210>  1
<211>  1021
<212>  DNA
<213>  Homo sapiens

<400>  1
agtcccaccc gggagccggc agggagcgga gctgcggagc cgcctggtct cccgcgtcca       60

tcggtccatt cctgcgtcgt tctgtccttc cgaacgcaca cttcaggagc agccgcgagg      120

gtggcatggc agcgagcaca gacatggctg ggctggagga gagcttccgc aagtttgcca      180

tccatggtga ccccaaggcc agtgggcaag agatgaatgg caagaactgg gccaagctgt      240

gcaaggactg caaggtggct gacggaaagt ccgtgacagg gaccgatgtg gacatcgtct      300

tctccaaagt caaggggaag tctgctcggg tcatcaacta tgaggagttc aagaaggccc      360

tggaagagct ggcgaccaag agattcaagg ggaagagcaa ggaggaggcc ttcgatgcca      420

tctgccagct ggtggcaggc aaagagccag ccaatgtggg cgtcactaaa gcaaaaacag      480

ggggtgctgt agaccggctg acggacacca gcagatacac gggctcccac aaggagcgct      540

tcgatgagag cggcaagggc aagggcattg cgggacggca ggacatcctg gacgacagtg      600

gctacgtgag cgcctacaag aatgcaggca cctacgatgc caaggtgaag aagtgaggct      660

tgggaagacc gccctgccaa gtgcggctgc ccctgccaga ggctcaggcc tgggtctaag      720

gggcacgtgg agcaagagat cctggtcccc tccctgctgg acctgccacc cagagcttcc      780

tgcctagtcc cactgggctg gcccaccagg cctctgaccc aggctgctct gcggcccctt      840

cctcctcctc ttcctgctcc aacttctgtc cacctgggga cagtctgtgc ctgtagcctc      900

atgaccccaa cccagcccca ggcatggcta acccctgact gcttgcctca tatttaagct      960

gctgctctgg ccaagtgcct aattttaacc cagacctcaa taaagacacc ttttgtacca     1020

a                                                                     1021


<210>  2
<211>  176
<212>  PRT
<213>  Homo sapians

<400>  2

Met Ala Ala Ser Thr Asp Met Ala Gly Leu Glu Glu Ser Phe Arg Lys 
1               5                   10                  15      


Phe Ala Ile His Gly Asp Pro Lys Ala Ser Gly Gln Glu Met Asn Gly 
            20                  25                  30          


Lys Asn Trp Ala Lys Leu Cys Lys Asp Cys Lys Val Ala Asp Gly Lys 
        35                  40                  45              


Ser Val Thr Gly Thr Asp Val Asp Ile Val Phe Ser Lys Val Lys Gly 
    50                  55                  60                  


Lys Ser Ala Arg Val Ile Asn Tyr Glu Glu Phe Lys Lys Ala Leu Glu 
65                  70                  75                  80  


Glu Leu Ala Thr Lys Arg Phe Lys Gly Lys Ser Lys Glu Glu Ala Phe 
                85                  90                  95      


Asp Ala Ile Cys Gln Leu Val Ala Gly Lys Glu Pro Ala Asn Val Gly 
            100                 105                 110         


Val Thr Lys Ala Lys Thr Gly Gly Ala Val Asp Arg Leu Thr Asp Thr 
        115                 120                 125             


Ser Arg Tyr Thr Gly Ser His Lys Glu Arg Phe Asp Glu Ser Gly Lys 
    130                 135                 140                 


Gly Lys Gly Ile Ala Gly Arg Gln Asp Ile Leu Asp Asp Ser Gly Tyr 
145                 150                 155                 160 


Val Ser Ala Tyr Lys Asn Ala Gly Thr Tyr Asp Ala Lys Val Lys Lys 
                165                 170                 175     


